Indoco Remedies Limited has informed the Exchange regarding Demise of Mr Anand Nadkarni , Non- Executive Director of the company on May 15, 2026.

Management Changes View source PDF Explain this filing

INDOCO · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close

+0.0%Reaction day

₹224.90

prior close

₹227.88

announcement price

In-mkt

timing

Nifty Microcap 250market · in no size index; the smallest one is used-0.4%+0.4% vs market

Pharmaceuticals peers, median of 160sector-0.2%+0.2% vs sector

On the reaction day the stock moved 0.4 pts more than Nifty Microcap 250 and 0.2 pts more than its Pharmaceuticals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark

Stock

+0.0

10m

-0.5

15m

-0.3

30m

-1.1

Sessions after the filingfrom the prior close

StockMarketvs marketSectorvs sector

Reaction day

+0.0-0.4+0.4-0.2+0.2

Next day

-4.4-1.7-2.7-0.9-3.5

-5.1-1.3-3.8-0.2-4.8

-6.4-0.7-5.7+0.3-6.7

-8.9+0.4-9.3+1.1-10.0

-11.1+0.5-11.6+0.2-11.3

-14.6+2.8-17.4+1.0-15.6

15d

-11.8+1.2-13.0-0.2-11.6

+6.6+5.3+1.3+1.5+5.2

+11.0+9.9+1.1+7.7+3.3

-3.0+13.1-16.1+8.1-11.2

UpDownMarket · Nifty Microcap 250Sector · Pharmaceuticals peers, median of 160Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

Indoco Remedies Limited announced the death of Dr. Anand Nadkarni, Non-Executive Director (DIN: 06881461), on May 15, 2026. The company described his association as a director as having immensely benefited the company. The death was sudden and unexpected, with the company stating it will be an irreparable loss. The intimation was made under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. Dr. Nadkarni served as a Non-Executive Director and his cessation date is recorded as May 15, 2026.

Likely market impact

The unexpected passing of a Non-Executive Director represents a loss of board experience and may have a minor negative sentiment impact on the stock in the short term, as investors often react cautiously to leadership changes, even when non-executive.